GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoZenge AB (OSTO:ONCOZ) » Definitions » Price-to-Funds-From-Operations

OncoZenge AB (OSTO:ONCOZ) Price-to-Funds-From-Operations : (As of Apr. 24, 2025)


View and export this data going back to 2021. Start your Free Trial

What is OncoZenge AB Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


OncoZenge AB Business Description

Industry
Traded in Other Exchanges
N/A
Address
Gustavslundsvagen 34, Bromma, SWE, 167 51
OncoZenge AB is a pharmaceutical company that is developing a new treatment for effective pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer. In phase 2 patient studies, the company's product candidate BupiZenge displayed pain relief compared with standard therapy. It focuses on implementing a phase development program as a basis for regulatory approvals and product launches.